Cabaletta Bio Inc.

10/15/2021 | Press release | Distributed by Public on 10/15/2021 14:33

Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential Precision Therapy for Antigen-Specific B Cell Depletion in PLA2R Membranous[...]